Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
ASX News
November 27, 2022
Emyria accepted into National Institutes of Health Preclinical Screening Platform for Pain program
October 17, 2022
MDMA Webinar recording
September 19, 2022
Emyria commences US preclinical program with PsychoGenics
June 2, 2022
Investor Webinar | Drug Development
March 7, 2022
ShareCafe Small Cap “Hidden Gems” Webinar
October 27, 2021
Presentation | South-West Connect Event
September 28, 2021
Video | Proactive Biosciences Webinar
June 9, 2021
Investor Webinar | Emyria validated care model
April 9, 2021
Investor Webinar | Emyria and Cann Group Partnership
March 16, 2021
Presentation: Dr Michael Winlo on Broker Briefing
Load More
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised